3rd Quarter - Report

PRIME POLICY GROUP for KEDRION BIOPHARMA

Firm
Client
Income
$170,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Pharmaceutical tariffs

Foreign entity interest: Pharmaceutical tariffs

LobbyistCovered position, as disclosed
VILLEM BERGLUND —
CASIE ELIZABETH DAUGHERTY —

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.